Fact checked by Nick Blackmer Eli Lilly decreased the prices of Zepbound and introduced higher-dose options to make the ...

Eli Lilly is cutting introductory Zepbound prices again, with the lowest dose now $299 monthly for cash-pay customers, a $50 ...

Eli Lilly reduced Zepbound vial prices for self-paying patients via LillyDirect, aiming to lower obesity treatment costs and improve access. Price reductions include $50 off the 2.5 mg vial and $100 ...

INDIANAPOLIS — Eli Lilly announced Wednesday the launch of higher doses of Zepbound — and that the company is lowering the price of certain doses. People taking Zepbound, or interested in starting, ...

With a valid prescription, patients can access the starting dose of Zepbound single-dose vial (2.5 mg) for as low as $299 per ...

The decision is the latest in a series of moves to make its GLP-1 blockbuster more widely available and affordable.

(RTTNews) - Eli Lilly and Company (LLY) has launched 7.5 mg and 10 mg Zepbound single-dose vials for $499 under the Zepbound Self Pay Journey Program, making the obesity medication more affordable for ...

This is the second time the company has cut down prices of Zepbound on LillyDirect. Eli Lilly said it was making the weight loss drug more accessible to people suffering from obesity.

The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg (Reuters) -Eli Lilly will ship the two highest doses ...

Eli Lilly slashes Zepbound to £227 ($299) monthly for US cash payers, but just £31 ($41) in India – though £241 ($319) in Japan.

US pharma major Eli Lilly (NYSE: LLY) has lowered the price of Zepbound (tirzepatide) single-dose vials on its Lilly Direct ...

Eli Lilly & Co. is cutting the price for introductory doses of its weight-loss drug Zepbound again, as competition heats up ...